Luxembourg’s Exobiosphere raises €2M to accelerate drug discovery in space; here’s why and how - Silicon Canals
2 Articles
2 Articles
Luxembourg’s Exobiosphere raises €2M to accelerate drug discovery in space; here’s why and how - Silicon Canals
Luxembourg-based Exobiosphere, the world’s first contract research organisation dedicated to drug discovery in space, has raised €2M in a seed funding round. The round was led by Expansion Ventures, with participation from Expon Capital, Boryung, and Space Data Inc. Expansion Ventures is a €200M pan-European venture capital fund backing category-defining founders in aerospace and defence. “Exobiosphere brings a fresh, high-impact perspective to …
Is space the new frontier for biotech? Exobiosphere lands €2M to accelerate drug discovery beyond Earth
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round. The post Developing drugs from outer space: Exobiosphere raises €2 million appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage